BBH vs. TFIF, MRCH, SDP, JFJ, NBPE, GSCT, SYNC, ICGT, APEO, and VOF
Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include TwentyFour Income (TFIF), Merchants Trust (MRCH), Schroder Investment Trust - Schroder AsiaPacific Fund (SDP), JPMorgan Japanese (JFJ), NB Private Equity Partners (NBPE), The Global Smaller Companies Trust (GSCT), Syncona (SYNC), ICG Enterprise Trust (ICGT), abrdn Private Equity Opportunities Trust (APEO), and VinaCapital Vietnam Opportunity Fund (VOF). These companies are all part of the "asset management" industry.
TwentyFour Income (LON:TFIF) and Bellevue Healthcare (LON:BBH) are both small-cap financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations.
In the previous week, TwentyFour Income had 2 more articles in the media than Bellevue Healthcare. MarketBeat recorded 3 mentions for TwentyFour Income and 1 mentions for Bellevue Healthcare. Bellevue Healthcare's average media sentiment score of 0.00 beat TwentyFour Income's score of -0.25 indicating that TwentyFour Income is being referred to more favorably in the media.
57.7% of TwentyFour Income shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 0.1% of TwentyFour Income shares are owned by company insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
TwentyFour Income is trading at a lower price-to-earnings ratio than Bellevue Healthcare, indicating that it is currently the more affordable of the two stocks.
TwentyFour Income pays an annual dividend of GBX 10 per share and has a dividend yield of 9.7%. Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.3%. TwentyFour Income pays out -33,333.3% of its earnings in the form of a dividend. Bellevue Healthcare pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. TwentyFour Income is clearly the better dividend stock, given its higher yield and lower payout ratio.
Bellevue Healthcare received 24 more outperform votes than TwentyFour Income when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 64.44% of users gave TwentyFour Income an outperform vote.
Summary
TwentyFour Income beats Bellevue Healthcare on 6 of the 10 factors compared between the two stocks.
Get Bellevue Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bellevue Healthcare Competitors List
Related Companies and Tools
